Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Cash Flow Reinvestment Rate
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd cash flow reinvestment rate. Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Cash Flow Reinvestment Rate of 4.72x as of December 2024, reinvesting CN¥24.11 Million (capex CN¥24.11 Million ) from operating cash flow of CN¥5.11 Million. Explore 300534 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2024)
Cash flow reinvestment rate of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2024. Historical reinvestment intensity for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd across 13 annual periods. Explore Gansu Longshenrongfa Pharmaceutical Indu capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Cash Flow Reinvestment Rate by Year (2011–2024)
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd cash flow reinvestment rate by year from 2011 to 2024. Year-by-year capital reinvestment analysis for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. For the full cash flow conversion analysis, see Gansu Longshenrongfa Pharmaceutical Indu cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.46x | CN¥78.82 Million | CN¥170.14 Million | CN¥78.22 Million | ▼ -82.3% |
| 2023 | 2.62x | CN¥252.72 Million | CN¥96.53 Million | CN¥126.36 Million | ▲ +13.6% |
| 2022 | 2.31x | CN¥26.34 Million | CN¥11.43 Million | CN¥13.63 Million | ▲ +14427.4% |
| 2021 | 0.02x | CN¥811.35K | CN¥51.13 Million | CN¥413.70K | ▼ -98.1% |
| 2020 | 0.84x | CN¥36.50 Million | CN¥43.50 Million | CN¥18.55 Million | ▼ -69.9% |
| 2019 | 2.79x | CN¥78.65 Million | CN¥28.21 Million | CN¥28.52 Million | ▲ +529.3% |
| 2018 | 0.44x | CN¥4.53 Million | CN¥10.23 Million | CN¥2.78 Million | ▼ -94.5% |
| 2016 | 8.01x | CN¥105.23 Million | CN¥13.14 Million | CN¥53.03 Million | ▲ +47.1% |
| 2015 | 5.45x | CN¥166.66 Million | CN¥30.60 Million | CN¥164.66 Million | ▲ +113.8% |
| 2014 | 2.55x | CN¥99.35 Million | CN¥39.01 Million | CN¥99.35 Million | ▲ +50.1% |
| 2013 | 1.70x | CN¥60.94 Million | CN¥35.92 Million | CN¥60.94 Million | ▲ +150.2% |
| 2012 | 0.68x | CN¥24.15 Million | CN¥35.62 Million | CN¥24.15 Million | ▼ -43.6% |
| 2011 | 1.20x | CN¥12.21 Million | CN¥10.16 Million | CN¥12.21 Million | — |